Italian researchers have demonstrated that immunoblot testing for anti-F-actin antibodies delivers diagnostic accuracy equivalent to established ELISA methods in autoimmune hepatitis type 1. The study reveals comparable specificity and overall performance metrics, potentially offering laboratories enhanced diagnostic flexibility for this rare but serious liver condition.
German life science instrumentation company Eppendorf has commercially launched its Research 3 neo mechanical pipettes, designed to deliver improved accuracy and ergonomic performance for laboratory applications. Following successful regional deployment across Asia in August, the pipettes are now available in EMEA and Americas markets.
Thermo Fisher Scientific has launched the Olink Target 48 Neurodegeneration panel, a targeted proteomics immunoassay designed to support neurodegenerative disease research. The panel provides simultaneous measurement of 41 key and emerging proteins with absolute quantification, optimised for plasma analysis using as little as 1µL of sample.
Sapio Sciences has introduced what it says is the world’s first third-generation Electronic Lab Notebook (ELN) that incorporates agentic artificial intelligence to function as a scientific collaborator. The platform, termed Sapio ELaiN, represents a departure from traditional electronic notebooks by actively participating in research workflows rather than simply documenting experimental procedures.
Agilent unveils Dako Omnis 165 Duo automated staining platform
Intelsint showcases EFTP Plus tissue processor with RFID technology
Biotech Fluidics has expanded its portfolio of barbed peristaltic tube connectors, introducing a specialised tubing stop adapter designed to streamline laboratory fluid handling systems. The Swedish company’s latest development addresses connection challenges in peristaltic pump applications in clinical and research laboratories.
Cambridge-based CN Bio has expanded its contract research services by integrating PhysioMimix computational modelling tools with existing organ-on-chip platforms, creating a comprehensive approach to absorption, distribution, metabolism and excretion (ADME) profiling for pharmaceutical development.
Dutch biotechnology company ProteoNic has announced the commercial launch of its 2G UNic transposon platform, combining established vector technology with proprietary transposon systems to improve cell line productivity and reduce development timelines for complex biologics manufacturing.
EpiCypher has launched CUTANA® Fiber-seq, a multiomic genomics platform that simultaneously captures genomic and epigenomic information through single long-read sequencing assays. The Durham, North Carolina-based company announced the technology on 3 September 2025, marking a significant development in molecular genomics capabilities.
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.